Navigation Links
Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
Date:11/13/2009

etting. The company is currently developing IV acetaminophen, an investigational product candidate for the treatment of acute pain and fever. For more information about Cadence, please visit www.cadencepharm.com.

Forward-Looking Statements

Statements included in this press release that are not a description of historical facts are forward-looking statements. Words such as "believes," "expects," "anticipates," "planning," "will," and "potential," and similar expressions, are intended to identify forward-looking statements, and are based on Cadence's current beliefs and expectations. Forward-looking statements include statements regarding: the potential that the FDA will approve Cadence's NDA for IV acetaminophen by the extended PDUFA goal date; the company's plans to accelerate the development of its commercial and supply operations infrastructure; and the timing of the launch of IV acetaminophen. The inclusion of forward-looking statements such as these should not be regarded as a representation by Cadence that any of its plans will be achieved. Actual results may differ materially from those set forth in this press release due to the risks and uncertainties inherent in the company's business, including, without limitation: the possibility that the FDA may not approve the NDA for IV acetaminophen if the agency determines that the clinical, non-clinical or other data submitted in the NDA are not adequate to support the safety or efficacy of this product candidate, or the agency may require us to conduct additional studies or clinical trials; the possibility that pre-approval inspections by the FDA of the site where IV acetaminophen is manufactured, or Cadence's clinical trial sites, may raise issues that must be resolved prior to obtaining approval of the NDA; the risk that increased attention to drug safety issues may result in a more cautious approach by the FDA, which could d
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
2. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
4. Cadence Pharmaceuticals Updates Omigard(TM) Clinical Timeline
5. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
6. Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
7. Cadence Pharmaceuticals to Webcast October 7th Analyst Day
8. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009
9. Cadence Pharmaceuticals CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
10. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... 1, 2015 Ansell, a global ... winners of the first Ansell Cares ® ... Nurses. The 2015 award, organised in partnership with the ... who display exceptional skill and quality in patient care, ... development. Award ceremonies are taking place today in the ...
(Date:6/30/2015)... -- IGI Laboratories, Inc. (NYSE MKT: IG), a ... today announced it has submitted its fifth abbreviated new ... Administration (FDA) of 2015, which brings the Company,s total ... to twenty-seven. Jason Grenfell-Gardner , President ... current pipeline of twenty-seven submissions, exclusive of our four ...
(Date:6/30/2015)... , June 30, 2015  A new report ... a campaign to promote public education and training opportunities ... and defibrillation. Annual rates of CPR ... percent in the United States ... cardiac arrest survival. The American Red Cross strongly supports ...
Breaking Medicine Technology:Ansell Announces European O.R. Nurse Hero Award Winners 2Ansell Announces European O.R. Nurse Hero Award Winners 3IGI Laboratories, Inc. Announces Fifth ANDA Submission Of 2015 2New Recommendations in Cardiac Arrest Protocol Advocate for Increased CPR and AED Training to Improve U.S. Survival Rates 2New Recommendations in Cardiac Arrest Protocol Advocate for Increased CPR and AED Training to Improve U.S. Survival Rates 3New Recommendations in Cardiac Arrest Protocol Advocate for Increased CPR and AED Training to Improve U.S. Survival Rates 4
... Carl Zeiss Group is adopting AT&T ... suppliers and subsidiaries around the world, across three continents. ... leader in the optical and optoelectronics industry with around ... countries Carl Zeiss will connect sites in Germany ...
... Health care costs are increasing, but NeedyMeds.org ... save money while staying healthy. NeedyMeds.org is ... discounts on prescription medications and other medical needs.  Consumer ... both English and Spanish regarding cost savings on prescription ...
Cached Medicine Technology:AT&T Helps Make The World a Smaller Place for Carl Zeiss 2AT&T Helps Make The World a Smaller Place for Carl Zeiss 3AT&T Helps Make The World a Smaller Place for Carl Zeiss 4Non-Profit Offers 3 Easy Consumer Tips to Save on Prescriptions 2
(Date:6/30/2015)... ... June 30, 2015 , ... The LIV Fertility Center in Puerto Vallarta ... the right age to pursue egg freezing. Statistics show that 20 percent of women ... a 150 percent increase since the 1970s. , Sadly, for women who have delayed ...
(Date:6/30/2015)... Grand Terrace, CA (PRWEB) , ... June 30, ... ... its Five-Star Medicare rating in a new video, “Grand Terrace Health Care Center.” ... keep facilities accountable and help patients find the best facility for their needs. ...
(Date:6/30/2015)... Port Richey, FL (PRWEB) , ... June 30, 2015 , ... ... use nearly doubled from 2007 to 2013 while heroin-related deaths more than tripled in ... greatest drug threat (1). Novus Medical Detox Center , a leading Florida-based drug ...
(Date:6/30/2015)... ... 2015 , ... ADVOCATE, the premier provider of radiology revenue ... billing agreements with Jackson Radiology Associates in Jackson, TN. , ADVOCATE ... billing process software functionality called Experience Based Technology (EBTTM). EBTTM improves radiology ...
(Date:6/30/2015)... ... June 30, 2015 , ... On June 26, 2015, Harper’s Bazaar ... five triggers that most people would not expect to cause acne flare-ups. ... primary causes of acne are clogged pores and bacteria and each of ...
Breaking Medicine News(10 mins):Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 2Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 3Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 4Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 5Health News:Grand Terrace Health Care Center Announces Five-Star Rating in YouTube Video 2Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 2Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 3Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 4Health News:ADVOCATE Wins Billing Agreements with Jackson Radiology Associates 2Health News:A List of 5 Surprising Acne Triggers and the Latest Acne Treatment Options 2
... , 70 Years of Service Excellence and Innovation Leads ... to Improve Patient Care and Increase Productivity , ... interoperability of disparate healthcare IT systems, announced today that ... Radiology Associates of the Fox Valley (RAFV) of Neenah, ...
... , CARLSBAD, Calif., June 5 Isis Pharmaceuticals, Inc. (Nasdaq: ... management will present a company overview at the 8th Annual Needham ... ET at the New York Palace Hotel. , ... on the "Investor Center" section of the Company,s Web site, ...
... ... London Clinic. The contract marks the world,s first live site of the company,s latest Rhapsody™ ... Auckland, ... workflow and integration technology for the health care sector world-wide, has signed a contract with ...
... ... to his distinguished career as attorney in Maryland , ... Columbia, Maryland (Lexis Nexis) -- Bruce Plaxen, founding ... as the 2008 Maryland Trial Lawyer of the Year by the non-profit Maryland Association ...
... They Would During Any Flu Outbreak , , HARRISBURG, Pa., ... Novel Influenza A/H1N1 was reported today in Berks County. Currently, the ... due to this virus. Nationally, there are 11,054 confirmed cases of ... this 55-year-old woman is a sad reminder of the complications that ...
... June 4 Today, in Los Angeles, Univision, People en Espanol, ... to the Latino community as la Doctora Aliza (TM), announced ... (TM). , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090604/SF28145 ) ... the largest source of health information and wellness tools in Spanish ...
Cached Medicine News:Health News:Compressus Initiates Enterprise Workflow Management Implementation at Radiology Associates of Fox Valley 2Health News:Compressus Initiates Enterprise Workflow Management Implementation at Radiology Associates of Fox Valley 3Health News:Orion Health Live at Harley Street Clinic 2Health News:Orion Health Live at Harley Street Clinic 3Health News:Bruce Plaxen Named 2008 Maryland Trial Lawyer of the Year by Maryland Association for Justice 2Health News:Health Department Reports Pennsylvania's First Death Due to 2009 Novel Influenza A/H1N1 Virus 2Health News:Univision's Doctora Aliza Launches VidaySalud.com(TM) 2
... a new level of immunodiagnostic productivity. Optimal ... any laboratory automation system. No-pause loading of ... the only immunoassay system with this capability. ... runs without any additional setup. Continuous sample ...
... Engineered for small and medium volume laboratories, ... 1010 System offers the speed, simplicity and ... requirements. Compact yet powerful, the Elecsys 1010 ... rapid response assays to routine testing without ...
... Behring's Dimension clinical chemistry integrated systems combine ... reagent cartridge, the power of the Multiply ... of the heterogeneous module to meet the ... and broad test menus, the systems can ...
The Embla 96/384 well washer is a top-loading, robotic-compatible plate washer for 96- and 384-well microplate washing. It is ideal for ELISAs and most cell applications....
Medicine Products: